Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-TMPRSS2 antibodies and antigen-binding fragments

Anti-TMPRSS2 antibodies and antigen-binding fragments

US Patent 10941213 · Granted Mar 9, 2021

Estimated economic value: $90,470,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PfRH5 antibodies and antigen-binding fragments thereof2024
Anti-TMPRSS2 antibodies and antigen-binding fragments2024
Anti-TMPRSS2 antibodies and antigen-binding fragments2024
Rodents having a humanized TMPRSS gene2024
Human antibodies to influenza hemagglutinin2023
Anti-PfRH5 antibodies and antigen-binding fragments thereof2023
Anti-TMPRSS2 antibodies and antigen-binding fragments2023
Human antibodies to influenza hemagglutinin2022
Rodents having a humanized TMPRSS gene2020
Human antibodies to influenza hemagglutinin2020
Angiopoietin-based interventions for treating cerebral malaria2020
Human antibodies to influenza hemagglutinin2019